Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

Feature

From the Field
Referral Patterns and Treatment Preferences in Patients With Advanced Prostate Cancer: Differences Between Medical Oncologists and Urologists
10/20/2021
Ajeet Gajra, MD, FACP
Skyler Hime Rupard, MS
Yolaine Jeune-Smith, PhD
Bruce Feinberg, DO
Ajeet Gajra, MD, FACP, et al assessed the differences between medical oncologists and urologists regarding perceptions on timing of referral and treatment sequence decisions for patients with advanced prostate cancer
Ajeet Gajra, MD, FACP, et al assessed the differences between medical oncologists and urologists regarding perceptions on timing of referral and treatment sequence decisions for patients with advanced prostate cancer
Ajeet Gajra, MD, FACP, et al...
10/20/2021
Journal of Clinical Pathways
Research Reports
Patterns and Predictors of Treatment Choice in a Real-World Cohort of Patients with Metastatic Gastric Cancer in the United States
09/22/2021
Thomas A Abrams, MD
Gary Meyer, PhD
Lisa M Hess, PhD
Sui Zhang, MS, MPP
Astra M Liepa, PharmD
Yajun Zhu, MS
Jeffrey A Meyerhardt, MD, MPH
Deborah Schrag, MD, MPH
Peter C Enzinger, MD
Charles S Fuchs
Thomas A. Abrams, MD, and colleagues examine patterns of systemic therapy administration in metastatic gastric cancer and the predictors associated with specific treatment choices.
Thomas A. Abrams, MD, and colleagues examine patterns of systemic therapy administration in metastatic gastric cancer and the predictors associated with specific treatment choices.
Thomas A. Abrams, MD, and...
09/22/2021
Journal of Clinical Pathways

Advertisement

Research Reports
Treatment and Outcomes Among Hospitalized COVID-19 Patients With Immune-mediated Inflammatory Diseases: An Electronic Health Record Database Cohort Study
08/20/2021
Alex Z Fu, PhD
Qian Cai, MSPH, MS
Emily S Brouwer, MPH, PharmD PhD
Christopher D Pericone, PhD
Kimberly Woodruff, PharmD, PhD
Alex Z Fu, PhD, and colleagues explore treatment journeys and outcomes for hospitalized COVID-19 patients with rheumatoid arthritis, psoriatic arthritis, psoriasis, Crohn's disease, or ulcerative colitis.
Alex Z Fu, PhD, and colleagues explore treatment journeys and outcomes for hospitalized COVID-19 patients with rheumatoid arthritis, psoriatic arthritis, psoriasis, Crohn's disease, or ulcerative colitis.
Alex Z Fu, PhD, and colleagues...
08/20/2021
Journal of Clinical Pathways
From the Field
Anticipated Cost Savings with Alternate Dosing Schema of Nivolumab/Ipilimumab for the Treatment of Metastatic Melanoma
08/20/2021
Allison Kupsh, PharmD
Laura Alwan, PharmD
Eve Segal, PharmD
Kate Trieselmann, PharmD
Evan Hall, MD
Allison Kupsh, PharmD, and colleagues found that the anticipated cost of NIVO3+IPI1 for the treatment of metastatic melanoma may be lower compared when compared with NIVO1+IPI3, amounting to over $1,000,000 in total savings.
Allison Kupsh, PharmD, and colleagues found that the anticipated cost of NIVO3+IPI1 for the treatment of metastatic melanoma may be lower compared when compared with NIVO1+IPI3, amounting to over $1,000,000 in total savings.
Allison Kupsh, PharmD, and...
08/20/2021
Journal of Clinical Pathways
Research Reports
Effectiveness of Eribulin in Metastatic Breast Cancer Patients With Poor Prognostic Indicators in the United States
06/21/2021
Sarah S Mougalian, MD
Jingchuan Zhang, PhD
Talia Miller, MSW, MPH
Marjorie E Zettler, PhD, MPH
Bruce A Feinberg, DO
A retrospective real-world study demonstrates the clinical effectiveness of eribulin in subgroups of MBC patients with poor prognostic characteristics, when used in accordance with the approved US indication.
A retrospective real-world study demonstrates the clinical effectiveness of eribulin in subgroups of MBC patients with poor prognostic characteristics, when used in accordance with the approved US indication.
A retrospective real-world study...
06/21/2021
Journal of Clinical Pathways

Advertisement

Research Reports
US Value-Based Management of Oncology Drugs: An Explorative Study of Payer and Provider Tools to Manage the Rising Spending on Oncology Drugs
06/21/2021
Anne Runyan, BA
Daniele Severi-Bruni, MS
Kolajo Salako, BS
Oliver Walker, PhD
Anne Runyan, BA , and colleagues point out that, despite increasing cancer costs in the United States, payers’ willingness and ability to manage oncology drugs remains limited.
Anne Runyan, BA , and colleagues point out that, despite increasing cancer costs in the United States, payers’ willingness and ability to manage oncology drugs remains limited.
Anne Runyan, BA , and colleagues...
06/21/2021
Journal of Clinical Pathways
Overactive Bladder Health Care Burden in the US Long-Term Care Setting: A Retrospective Cohort Study
Research Reports
Overactive Bladder Health Care Burden in the US Long-Term Care Setting: A Retrospective Cohort Study
05/18/2021
Richard G Stefanacci, DO
Jason Yeaw, MPH
Drishti Shah, PhD
Amy Kincaid, MA
Paul N Mudd Jr, PharmD, MBA
Richard Stefanacci, DO, and colleagues describe and evaluate the population, treatment patterns, HCRU, and costs associated with overactive bladder in the in the US long-term care setting.
Richard Stefanacci, DO, and colleagues describe and evaluate the population, treatment patterns, HCRU, and costs associated with overactive bladder in the in the US long-term care setting.
Richard Stefanacci, DO, and...
05/18/2021
Journal of Clinical Pathways
Assessing Clinician Attitudes and Beliefs Around Financial Toxicity Screening in Medical Oncology Clinic
Research Reports
Assessing Clinician Attitudes and Beliefs Around Financial Toxicity Screening in Medical Oncology Clinic
05/17/2021
Sylvia T Zhang, MS
Errol J Philip, PhD
Nichole Legaspi
Lucky Ding
Tracy Kuo Lin, MSc, PhD
Hala T Borno, MD
Sylvia Zhang, MS, and colleagues discuss the attitudes, motivation, and experiences of clinicians regarding screening for financial toxicity in a medical oncology clinical setting, identifying potential opportunities for future clinician-led...
Sylvia Zhang, MS, and colleagues discuss the attitudes, motivation, and experiences of clinicians regarding screening for financial toxicity in a medical oncology clinical setting, identifying potential opportunities for future clinician-led...
Sylvia Zhang, MS, and colleagues...
05/17/2021
Journal of Clinical Pathways

Advertisement

Pediatric Sunscreen Coverage by Medicaid as a Primary Prevention Strategy to Reduce Melanoma Burden: A Cost-Effectiveness Analysis
Research Reports
Pediatric Sunscreen Coverage by Medicaid as a Primary Prevention Strategy to Reduce Melanoma Burden: A Cost-Effectiveness Analysis
04/22/2021
Dawn Queen, MD
Christine Lauren, MD
Richard D Carvajal, MD
Megan H Trager, MD
Connor Stonesifer, BA
Chin Hur, MD, MPH
Robert Stern, MD
Daniel C Malone, RPh, PhD, FAMCP
Larisa J Geskin, MD
Abstract: Melanoma treatment costs continue to rise. Sunscreen is a photoprotective tool that may reduce the incidence of melanoma but can be cost prohibitive for lower socioeconomic populations. New York State...
Abstract: Melanoma treatment costs continue to rise. Sunscreen is a photoprotective tool that may reduce the incidence of melanoma but can be cost prohibitive for lower socioeconomic populations. New York State...
...
04/22/2021
Journal of Clinical Pathways
Patient Voices in Value-Based Cancer Care: Priorities for the Biden Administration
Perspectives
Patient Voices in Value-Based Cancer Care: Priorities for the Biden Administration
04/22/2021
Theresa Schmidt, MA
Jacqlyn Riposo, MBA
Tom Valuck, MD, JD
Kimberly Westrich, MA
Ethan Basch, MD, MSc
Mark McClellan, MD, PhD
Abstract: The Biden administration has an opportunity to prioritize patient perspectives in innovative value-based payment models for oncology by incorporating meaningful patient-reported measures (PRMs) and...
Abstract: The Biden administration has an opportunity to prioritize patient perspectives in innovative value-based payment models for oncology by incorporating meaningful patient-reported measures (PRMs) and...
...
04/22/2021
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP May/June 2024 Issue

Current Issue

June 2024
Volume 10
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Winston Wong, PharmD
Gordon Kuntz
Robin T Zon, MD, FACP, FASCO
2021 Care Pathways Working Group
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
Special Report
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
01/14/2021
01/14/2021
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use